Viemed Healthcare Inc

Análisis de la acción Viemed Healthcare Inc (VMD)

$9.800

-0.119 (-1.21%)Al cierre

Loading chart…
Máximo
9.990
Apertura
9.910
Precio medio ponderado por volumen
9.85
Volumen
123.14K
Capitalización
251.17M
Mínimo
9.760
Importe
1.21M
EV/EBITDA, TTM
7.12

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services.

www.viemed.com

Análisis de IA of Viemed Healthcare Inc (VMD)

Comprar

Viemed Healthcare Inc is a good buy right now due to its current price of $9.80, which is significantly below the analyst price target of $14. The company has shown strong revenue growth, with Q2 revenue of $78.1 million, a 23.7% increase year-over-year, and a gross margin of 57.7%. However, the main risk is the earnings miss in the last report, where EPS was $0.07 compared to the expected $0.10, indicating potential profitability pressures.

Métricas de valoración

El PER previsto actual de Viemed Healthcare Inc (VMD) es 18.35, frente a su media de 5 años de 23.92.

PER previsto

Valor razonable
Media 5A P/E
23.92
P/E actual
18.35
Sobrevalorada
30.94
Infravalorada
16.91

EV/EBITDA previsto

Valor razonable
Media 5A EV/EBITDA
6.05
EV/EBITDA actual
7.12
Sobrevalorada
7.37
Infravalorada
4.72

Precio/ventas previsto

Valor razonable
Media 5A P/S
1.31
P/S actual
1.07
Sobrevalorada
1.65
Infravalorada
0.98

Escenarios de precio de Alphio AI para VMD

Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

A

Alcista

Alcista · 25%VMD

$9.49

Precio del escenario

B

Base

Base · 50%VMD

$8.88

Precio del escenario

B

Bajista

Bajista · 25%VMD

$7.16

Precio del escenario

Cronología de eventos

2026-03-04 (ET)

16:50:00

Viemed Healthcare Authorizes Share Repurchase Program Through March 2027

2025-07-02 (ET)

08:43:56

Viemed Healthcare completes acquisition of Lehan's Medical Equipment

2025-06-09 (ET)

08:18:09

Viemed Healthcare board authorizes share repurchase program up to 5%

2025-05-06 (ET)

08:32:47

Viemed entered into definitive agreement to acquire Lehan's Medical Equipment

2025-03-10 (ET)

17:02:06

Viemed Healthcare sees FY25 revenue $254M-$265M, consensus $251.43M

Noticias

Preguntas frecuentes sobre VMD, respondidas por Alphio AI

Viemed Healthcare, Inc. is an in-home clinical care provider of post-acute respiratory healthcare equipment and services in the United States, including non-invasive ventilators (NIV), sleep therapy, staffing, and other complementary products and services. The Company focuses on in-home treatment with clinical practitioners providing therapy, education and counseling to patients in their homes using high-touch and high-tech services. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment solutions, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, oxygen concentrators, breast pumps for women, respiratory devices and other medical equipment. It offers in-home sleep apnea testing services. The Company also provides healthcare staffing and recruitment services. It operates in the Healthcare sector (SERVICES-MISC HEALTH & ALLIED SERVICES, NEC industry).

Viemed Healthcare Inc is a good buy right now due to its current price of $9.80, which is significantly below the analyst price target of $14. The company has shown strong revenue growth, with Q2 revenue of $78.1 million, a 23.7% increase year-over-year, and a gross margin of 57.7%. However, the main risk is the earnings miss in the last report, where EPS was $0.07 compared to the expected $0.10, indicating potential profitability pressures.

Comunidad

Más ↗

Aún no hay publicaciones

Regístrate o inicia sesión para participar

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar